NASDAQ$RCMT

RCM Technologies Inc · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

RCM Technologies reported a decrease in revenue and experienced a net loss due to an impairment charge related to a customer dispute and the impact of the COVID-19 pandemic.

RCM Technologies reported a revenue of $45.0 million, a 12.7% decrease compared to the previous year. The company experienced a GAAP net loss of $5.9 million, or ($0.45) per diluted share, primarily driven by an $8.0 million impairment charge. The company is focused on cost and debt reduction and maximizing cash flow.

  • Revenue decreased by 12.7% compared to the same period last year.
  • GAAP net loss was $5.9 million, or ($0.45) per diluted share.
  • An $8.0 million impairment charge related to a customer dispute significantly impacted the operating loss.
  • COVID-19 pandemic negatively impacted the Healthcare segment, with an estimated $3.0 million revenue loss.

Headline financials

Total Revenue

$45M

Previous: $51.6M-12.7%
EPS (adj)

$0.16

Previous: $0.11+45.5%
Adjusted EBITDA

$606K

Previous: $2.05M-70.5%
Capital Expenditures

-$35K

Previous: -$101K+65.3%
Free Cash Flow

-$5.98M

Previous: $1.36M-539.1%
Net Income

-$5.95M

Previous: $1.46M-506.4%
Operating Income

-$7.78M

Previous: $1.65M-570.1%
Gross Profit

$10.8M

Previous: $12.5M-13.4%
Cash & Equivalents

$642K

Previous: $1.69M-62.1%
Total Assets

$84M

Previous: $92.8M-9.5%
Stock-Based Comp

$69K

No prior period

Revenue & EPS history

RCM Technologies · Revenue · Quarterly

$45M

Q1 2020-12.7%vs Q1 2019
Beat estimate in 5 of 15 quarters(33%)
ActualEstimate

Revenue by segment

RCM Technologies · $36.4M total across 2 segments · Q1 2020

  • Specialty Healthcare
    $22.2M
  • Engineering
    $14.2M

Forward guidance

During the next two quarters, the primary focus will be cost and debt reduction without sacrificing the long-term progress made in the business. The company is aggressively applying two principles across all three segments on a going-forward basis: 1) maximize utilization, and 2) reduce SGA expense as much as possible. A material reduction in debt is expected throughout the second and third quarters of 2020.

Tailwinds

  • Focus on cost and debt reduction.
  • Maximizing utilization across all segments.
  • Reducing SGA expense.
  • Expecting a material reduction in debt throughout the second and third quarters of 2020.
  • Positioned to grow in a post COVID world

Headwinds

  • Short-term revenue visibility is a challenge.
  • Slowing of new business inquiries and proposals in Engineering and IT segments.
  • Visibility beyond Q2 is challenging.
  • Healthcare segment lost approximately $3.0 million in revenue due to school closures.
  • Uncertainty regarding school openings for the 2020/2021 academic year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

-0.2%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+6.3%

Avg return

30 days after

46%

30 / 65 earnings

Positive

+48.2%

Q1 2022

Best reaction

-25.0%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+4.3%+10.5%
Q1 2026-0.6%-23.2%-11.8%
Q3 2025-9.3%-13.0%-9.6%
Q2 2025-4.6%+1.1%+14.9%
Q1 2025+0.8%-1.0%-2.1%
Q4 2024-13.5%-10.2%-10.9%
Q3 2024+5.2%+13.5%+5.1%
Q2 2024+6.1%+2.1%+4.6%
Q1 2024+8.8%+12.8%+2.7%
Q4 2023-25.0%-23.5%-32.4%
Q3 2023+14.7%+31.0%+41.7%
Q2 2023-12.3%+3.2%-1.5%
Q1 2023+5.1%+15.2%+39.2%
Q4 2022+0.3%-4.5%-6.3%
Q3 2022-12.3%-19.4%-28.2%
Q2 2022-16.3%-3.2%-6.0%
Q1 2022+48.2%+59.2%+106.2%
Q4 2021+11.9%+42.9%+98.4%
Q3 2021-0.8%+11.6%+30.1%
Q2 2021-3.8%-5.6%+35.7%
Q1 2021+0.6%+3.5%+9.8%
Q3 2020+3.7%+0.7%+22.2%
Q2 2020+2.5%+8.7%-11.3%
Q1 2020-17.9%-23.7%+18.4%
Q4 2019+5.1%+2.6%-47.1%
Q3 2019-4.4%-3.9%-12.7%
Q2 2019+8.1%+1.9%+8.4%
Q1 2019+0.0%-0.8%-14.7%
Q4 2018-8.7%-14.0%-6.2%
Q3 2018-2.1%-6.1%-12.0%
Q2 2018+1.3%+1.1%+0.0%
Q1 2018+0.2%+2.6%+3.0%
Q4 2017-2.8%-3.4%-7.7%
Q3 2017+7.7%+16.0%+16.2%
Q2 2017-1.5%+2.3%-0.4%
Q1 2017-0.6%+3.7%+13.1%
Q4 2016-4.7%-10.2%-17.9%
Q3 2016-10.7%-11.3%+5.3%
Q2 2016-0.9%-3.2%+2.8%
Q1 2016+0.6%
Q4 2015-5.6%
Q3 2015-1.1%
Q2 2015-8.2%
Q1 2015-5.3%
Q4 2014+8.1%
Q3 2014+6.3%
Q2 2014+6.7%
Q1 2014-0.5%
Q4 2013+0.6%
Q3 2013-2.9%
Q2 2013-0.9%
Q1 2013+4.6%
Q4 2012-0.9%
Q3 2012+0.9%
Q2 2012+2.0%
Q1 2012-2.5%
Q4 2011-0.2%
Q3 2011+0.2%
Q3 2010+0.2%
Q2 2011-1.0%
Q2 2010-1.0%
Q1 2011-2.1%
Q4 2010+6.5%
Q1 2010+5.1%
Q4 2009-1.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro